NOVEL Rebirth: Super Banking System Chapter 1306 - 1161: No Problem (Please Subscribe!)

Rebirth: Super Banking System

Chapter 1306 - 1161: No Problem (Please Subscribe!)
  • Prev Chapter
  • Background
    Font family
    Font size
    Line hieght
    Full frame
    No line breaks
    Text to Speech
  • Next Chapter

Chapter 1306: Chapter 1161: No Problem (Please Subscribe!)

"Wow~~~"

As soon as these words came out,

the conference venue was in an uproar.

This news,

how explosive can it get?

Cancer, if merely controllable, already qualifies as a revolutionary drug. Now the person above actually mentioned that it was possible to treat a large number of cancers; that’s just unbelievable.

This is defying the natural order!

"This is a treatment drug, as well as an auxiliary surgery drug. In controlling tumor complications and spread, it can achieve nearly a hundred percent effectiveness..." This universal formulation is truly today’s protagonist.

Other dozens of drugs,

are merely significantly effective.

They are not without alternatives.

But this one,

it’s impossible for the outside world to replicate and will be Myanmar Pharmaceutical Group’s primary source of profit, perhaps creating more than ninety-five percent of this company’s profit. Naturally, it demands a grand introduction.

As the explanation deepened,

those present at the Conference Venue gained an initial understanding of the ’Transcription Fluid’s’ effectiveness – it was powerful, extremely powerful. Combined with various medical methods, it could almost lead to the end of cancer.

My goodness.

Doctors in the audience felt a surge of pride, because it was them that conducted the clinical trials for this drug. They were the first to witness the birth of this century’s new drug, feeling invigorated.

Doctors.

Of course, hope to solve the patients’ pain.

But.

In the face of terminal illness, many times, they are actually helpless. These days, they saw one patient after another escape death and regain health. If it weren’t for confidentiality restrictions, they would have long wanted to tell the world.

Aside from doctors,

there were also thousands of patients about to be discharged; they were the first batch of clinical testing beneficiaries. They had thought their days were numbered, but unexpectedly, this company gave them so many surprises.

Their gratitude,

came from deep within.

Down in the audience,

Annesley was already dumbfounded.

Damn it.

I just planned to wander around.

Are you going to trample on me now? If this drug is real, one can imagine that in the future Myanmar’s international status and influence would skyrocket, making his work even more challenging.

As it was a live broadcast,

and indeed Myanmar’s mouthpiece TV station.

Those who saw,

all set aside their work, their faces incredulous. What did they just hear? Cancer has been conquered? Today doesn’t seem like April Fool’s Day, and besides, the station wouldn’t joke about such a matter.

And Kan Qin was there to support it.

A big close-up shot.

Made skeptical people drop their doubts.

On TV.

The fighter continued to introduce,

"All of our company’s drugs will be included in Myanmar’s medical insurance coverage. We will not forget our responsibilities, reducing everyone’s medical costs. Considering the limitation of available beds, we will initiate a special medical channel for major diseases."

"Based on physical examinations, cancer patients with fatal serious diseases will be given priority for treatment. Please be assured, our drug inventory is sufficient to supply the nationwide medical market."

To prevent hospitals from being overwhelmed,

this policy was thus established.

Conditions that could soon lead to death, or cause extreme suffering to the patients, were placed on a priority list, while cancer patients who had no notable symptoms and possibly ten or eight years left to live, were postponed.

In at most a year,

they could actually go through all patients here.

There was no neglect of anyone, priorities had to be set.

Although ’Transcription Fluid’ is a universal treatment drug, it cannot be prescribed carelessly. Different diseases require different doses, and each individual’s physical fitness is different, needing case-by-case attention.

"Due to the special nature of this medicine, we temporarily only sell it in major hospitals across Myanmar, and it must be used on-site. Please absolutely do not use or disseminate through any other channels."

"Here, I need to remind you, for any form of plastic surgery or organ-transplanted patients, they must inform their doctor, because the anti-cancer effect of this type of medicine will suppress non-self cell tissues."

"In this case, treatment will require a very expensive auxiliary medicine. Although such drugs are also included in the Myanmar medical insurance catalog, considering there might be patients from other countries, it will increase additional economic outlays."

The fighter solemnly warned,

Gene Stabilizing Drugs also have their downsides.

They have a ’corrective’ capability against abnormal cells, and also a repair capability for abnormal damages. For example, those who have undergone plastic surgery will definitely experience rejection reactions. Therefore, ’Transcription Fluid’ must be regulated.

It cannot be consumed carelessly.

After much research and development.

Scientists found a compound that could neutralize this rejection response. The cost is high, and the preparation process is quite complex, so Tang Qing set a very high price.

Since you have the money for plastic surgery,

You should spend more on treatment.

No problem.

Soon,

the Press Conference came to an end. Actually, Myanmar Pharmaceutical Group still had a lot of medical equipment and treatment technologies, but since these could only be used temporarily in Myanmar for now, they simply didn’t bother introducing them.

Good stuff.

No worry about selling.

Once everyone experiences the treatment capabilities here, all issues will resolve themselves.

Entering the question session.

"How much does this ’Transcription Fluid’ cost?"

"The price of the fluid depends on the concentration. The higher the concentration, the higher the price. Currently, we do not provide retail to individuals and enterprises; we only sell to pharmaceutical companies that meet a certain scale."

"For foreigners coming for treatment, is there a discount on the price?"

"Yes, considering different patients’ affordability, we have relevant policies. However, we still hope that various countries speed up the clinical review of such drugs to lessen the patients’ burden."

"Do you have any plans to disclose the preparation technology for this ’Transcription Fluid’ to the world?"

"I can say clearly that it’s impossible. If so, our company would not be able to sustain Myanmar’s medical system. We need the world market to subsidize the domestic medical funding gap."

This statement.

Very direct.

Very clear.

It also received unanimous applause from the audience in front of the TVs.

Myanmar Pharmaceutical Group.

Took on the burden of affordable medical care for all on behalf of the Myanmar government. The funds in the medical insurance pool might not be enough. If it was disclosed, and there was no money to be made, Group and Myanmar government would terminate the contract, and their medical costs would definitely rise.

Absolutely not allowed.

Looking at the American journalist who asked this question.

Millions of audiences sneered.

She looks pretty.

But she’s wicked.

One might say, this is a form of ’moral hijacking.’ The journalist didn’t seem upset at all, how did this topic come? Isn’t this a topic? They like this kind of truth-telling.

When the Press Conference ended,

media from various countries,

were completely dominated by this live broadcast. Hearing that they could purchase for study, many pharmaceutical companies prepared to buy some to experiment, seeing the price of the concentrate, which was more than ten times more expensive than gold, they promptly placed large orders without a second thought.

Use arrow keys (or A / D) to PREV/NEXT chapter